SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 18 filers reported holding SEATTLE GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $196,000 | -23.1% | 1,000 | -33.3% | 0.02% | -27.6% |
| Q2 2020 | $255,000 | +100.8% | 1,500 | +36.4% | 0.03% | +61.1% |
| Q1 2020 | $127,000 | +0.8% | 1,100 | 0.0% | 0.02% | +20.0% |
| Q4 2019 | $126,000 | +48.2% | 1,100 | +10.0% | 0.02% | +50.0% |
| Q3 2019 | $85,000 | +23.2% | 1,000 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $69,000 | -5.5% | 1,000 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $73,000 | +28.1% | 1,000 | 0.0% | 0.01% | +11.1% |
| Q4 2018 | $57,000 | -26.0% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $77,000 | -38.9% | 1,000 | -47.4% | 0.01% | -18.2% |
| Q2 2018 | $126,000 | +27.3% | 1,900 | 0.0% | 0.01% | +10.0% |
| Q1 2018 | $99,000 | -2.9% | 1,900 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $102,000 | -1.0% | 1,900 | 0.0% | 0.01% | +11.1% |
| Q3 2017 | $103,000 | +5.1% | 1,900 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $98,000 | -17.6% | 1,900 | 0.0% | 0.01% | -18.2% |
| Q1 2017 | $119,000 | – | 1,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |